Search - tctmd.com

Displaying 121 - 140 of 192

Sort: Relevancy | Date

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Daily News

VA Efforts to Cut HF Readmissions are Working, With No Uptick in Deaths

L.A. McKeown

June 18, 2020

News Daily News

Latest Kawasaki Series Offers Clues to COVID-19 in Kids as Debate Persists

Shelley Wood

May 14, 2020

News Daily News

Smartphones Aid in Remote Monitoring of Patients With Recent Acute MI

L.A. McKeown

April 21, 2020

News Daily News

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

Yael L. Maxwell

February 18, 2020

News Daily News

MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR

Shelley Wood

January 24, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

L.A. McKeown

December 06, 2019

News Conference News AHA 2019

Sex Differences, EF Thresholds Probed for Sacubitril/Valsartan in Heart Failure

Shelley Wood

November 22, 2019

News Daily News

Women More Likely Than Men to Develop Heart Failure After STEMI

L.A. McKeown

November 04, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Conference News HFSA 2019

Old Dog, New Tricks? HOMAGE Hints at Role for Spironolactone in HF Prevention

L.A. McKeown

September 24, 2019

News Conference News HFSA 2019

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

L.A. McKeown

September 18, 2019

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

L.A. McKeown

September 16, 2019

News Conference News ESC 2019

Primary Prevention ICDs Still Render Better Survival, Even in Modern HFrEF Patients

Todd Neale

September 13, 2019

News Daily News

High-Sensitivity Troponin T May Offer Glimpse Into Future HF Risk: ARIC Analysis

L.A. McKeown

September 13, 2019

News Industry News

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

September 12, 2019

News Conference News ESC 2019

PARAGON-HF Misses Primary Endpoint, but Hints of Benefit Seen

Todd Neale

September 01, 2019

News Daily News

STICH Myocardial Viability at 10 Years: Still No Link With CABG Effects

Todd Neale

August 21, 2019

News Daily News

CV Risk Factors in Youth May Prove Indelible for Later CAD

Marcus A. Banks

July 17, 2019

Advertisement

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

VA Efforts to Cut HF Readmissions are Working, With No Uptick in Deaths

Latest Kawasaki Series Offers Clues to COVID-19 in Kids as Debate Persists

Smartphones Aid in Remote Monitoring of Patients With Recent Acute MI

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

Sex Differences, EF Thresholds Probed for Sacubitril/Valsartan in Heart Failure

Women More Likely Than Men to Develop Heart Failure After STEMI

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Old Dog, New Tricks? HOMAGE Hints at Role for Spironolactone in HF Prevention

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

Primary Prevention ICDs Still Render Better Survival, Even in Modern HFrEF Patients

High-Sensitivity Troponin T May Offer Glimpse Into Future HF Risk: ARIC Analysis

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

PARAGON-HF Misses Primary Endpoint, but Hints of Benefit Seen

STICH Myocardial Viability at 10 Years: Still No Link With CABG Effects

CV Risk Factors in Youth May Prove Indelible for Later CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content